2Von Moltke LL, Greenblatt DJ, Duan SX, et al. Inhibition of desipramine hydroxylation (Cytochrome P450- 2D6) in vitro by quinidine and by viral protease inhibitors relation to drug interactions in vivo[J] . Pharm Sci, 1998, 87(10) : 1 184.
3Sproule BA, Naranjo CA, Brenmer KE, et al. Selective serotonin reuptake inhibitors and CNS drug interactions.A critical review of the evidence[J] .Clin Phar macokinet, 1997,33(6) ~ 454.
4Potkin SG, Thyrum PT, Alva G, et al .The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine[J ] .Clin Psychopha rmacol, 2002, 22(2) : 121.
5Suzuki Y, Someya T, Shimoda K, et al. Importance of cytochrome P450 2D6 genotype for the drug metabolic interaction between chlorpromazine and haloperidol[J]. Ther Drug Monit , 2001,23(4) : 363.
6Daniel WA,Wojcikowski J .The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions[J] . Toxicol Appl Pharmacol , 1999, 158 (2):115.
7Spina E, Avenoso A, Facciola G,et al. Effect of fluoxetine on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenia[J] . Clin Psychopharmacol, 1998,13(3) .. 141.
8Bork JA, Rogers T, Wedlund PJ, et al. A pilot study on risperidone metabolism: The role of eytoehromesP450 2D6 and 3A[J ] .J Clin Psychiatry, 1999,60(7) : 469.
9Cai WM, Chen B, Zhou Y, et al. Fluoxetine impairs the CYP2D6 - mediated metabolism, of propafeuone enantiomers in healthy Chinese volunteers[J] .Clin Pharmacol Ther, 1999,66(5) :516.
10Leibovitz A, Bilchinsky T, Gil I, et al. Elevated serum digoxin level associated with coadministered fluoxetine [J ] .Arch Intern ivied, 1998,158(10): 1 152.
